The p16 tumor suppressor gene is frequently inactivated in human cancer tissues and cell lines. We previously reported that wild-type p16 expression from an adenovirus vector (Adv/p16) induced p53-dependent apoptotic cell death in non-small cell lung cancer (NSCLC) cell lines. Here we show the potential mechanism of apoptosis induced by Adv/p16 infection. Infection of human NSCLC cell line A549, which carries the wild-type p53 gene, with Adv/p16 resulted in activation of caspase-3, accompanied by the cleavage of its substrate poly (ADP-ribose) polymerase (PARP), on day 3 of infection. The retinoblastoma (Rb) cell cycle regulator protein was also cleaved after activation of caspase-3; when the levels of Rb signi®cantly diminished, apoptosis began. When A549 cells were pretreated with the caspase-inhibitory peptide N-acetyl-asp-Glu-Val-Asp-CHO (aldehyde) (Ac-DEVD-CHO), Adv/p16-mediated apoptosis and Rb cleavage were greatly inhibited. Furthermore, MDM2, a negative regulator of p53 expression was upregulated 3 days after Adv/p16 infection, and MDM2 was subsequently cleaved by caspase-3; MDM2 cleavage was inhibited by Ac-DEVD-CHO treatment. These data implied that cleavage of Rb, in addition to activation of caspase-3, represented a mechanism by which Adv/p16 induced apoptotic cell death in human NSCLC cells. Our results support the clinical relevance of Adv/p16 as a treatment for p16-null human NSCLC that express wild-type p53.
The p16 tumor suppressor arrests the cell cycle at the G 0 /G 1 phase by inhibiting the cyclin-dependent kinase (cdk) 4: cyclin D complex, resulting in dephosphorylation of the retinoblastoma (Rb) protein (Weinberg, 1995; Foulkes et al., 1997) . Recently, it has been reported that p16 is involved in additional cellular functions such as induction of senescence (Steiner et al., 2000; Hara et al., 1996) and apoptosis (Sandig et al., 1997) . The p16 gene is frequently inactivated in a wide range of human tumors, including 50% of lung cancers (Haas et al., 1997; Otterson et al., 1994) , 40% of pancreatic cancers (Hu et al., 1997) , 49% of breast cancers (Musgrove et al., 1995) and 50% of esophageal cancers (Takeuchi et al., 1997) . Aberrant p16 expression is even more frequent in established human cancer cell lines. A molecular approach has demonstrated that p16 can be inactivated by DNA mutation (Mori et al., 1994; Nobori et al., 1994) , homozygous or heterozygous loss of the gene (Jen et al., 1994) or methylation of its promoter region (Herman et al., 1996; Mao et al., 1995) . These ®ndings suggest that p16 might be an appropriate molecular target of gene-based cancer therapy.
Exogenous expression of wild-type p16 gene by an adenovirus vector (Adv/p16) induces apoptosis in a p53-dependent manner (Kataoka et al., 2000; Sandig et al., 1997) . In addition, we have demonstrated that Adv/p16 infection dramatically reduces Rb and bcl-2 expression, and subsequently induces apoptosis in nonsmall cell lung cancer (NSCLC) cells lacking p16 expression. The fact that one of the functions of Rb is to inhibit apoptosis (Haas-Kogan et al., 1995; Hsieh et al., 1997; Haupt et al., 1995; Wang et al., 1997; McConkey et al., 1996) suggests that downregulation of Rb expression might be one of the key events in Adv/p16-mediated apoptosis. Therefore, we attempted to clarify the molecular mechanism of Rb downregulation induced by Adv/p16 infection. It has been reported that caspase-3, which plays a pivotal role in the terminal execution phase of apoptosis, and its substrate poly (ADP-ribose) polymerase (PARP) are activated during p16-mediated apoptosis (Kim et al., 2000) . We thus hypothesized that restoration of the wild-type p16 gene to human NSCLC cells would activate caspase-3, which in turn would induce downregulation of Rb, leading to apoptosis.
A cell proliferation assay was performed to evaluate the eect of adenovirus-mediated p16 expression on NSCLC cell growth in vitro. Human NSCLC A549 Figure 1 (a) Eect of Adv/p16 infection on the growth of A549 human NSCLC cells. Recombinant adenovirus vectors were based on the adenovirus serotype 5. Adv/p16, a gift from Dr Ta-Jen Liu (The University of Texas MD Anderson Cancer Center, Houston, TX, USA), contained p16 cDNA inserted into the E1 region of the viral genome, driven by the CMV enhancer/promoter. The E1A-deleted adenovirus vector dl312 was used as a control vector. Cells (1610 5 ) were plated 24 h before infection and cultured with either Adv/p16 or dl312 at 100 MOI for an additional 48 h. Cells were collected for Trypan blue staining to identify viable cells. Each experiment was performed at least three times. The arrow indicates the time of infection. Data represent the means (+s.d.) of three independent experiments. Statistical analysis was performed using the Dunnett multiple comparisons test for determining dierences among groups. Statistical signi®cance was de®ned as P50.05. (b) Western blot analysis to detect p16, Rb, MDM2, and p53 proteins in Adv/p16-transduced A549 cells. A549 cells were infected with Adv/p16 at 100 MOI, and then collected daily for 7 days. Cells were pelleted and lysed with ice-cold lysis buer (50 mM PIPES/NaOH (pH 6.5), 2 mM EDTA, 0.1% Chaps, 5 mM DTT, 20 mg/ml of leupeptin, 10 mg/ml of pepstatin and 1 mM PMSF). The cell lysate was incubated with ice-cold 10% trichloroacetic acid (TCA) for 30 min to inactivate endogenous proteinases. After brief centrifugation, excess TCA was removed from the cell pellet by washing with PBS. The cells were then treated with urea buer (9 M urea, 2% Triton X-100 and 2 mM DTT) for 30 min on ice. The cell lysate was centrifuged at 15 000 r.p.m. for 20 min and the supernatant was recovered. Protein concentration was measured using Bradford's method. Protein samples were then stored at 7808C until use. Protein samples (50 ± 70 mg each) were separated with 7 ± 15% SDS ± PAGE and electroblotted onto a nitrocellulose membrane. After blocking with 5% skimmed milk in TBS-T (10 mM Tris-HCl (pH 7.3), 150 mM NaCl, and 1% Tween 20) for 1 h at 378C, membranes were then incubated overnight at 48C with primary antibodies: goat anti-human p16 polyclonal antibody (C-20) at 1 : 800 dilution, mouse anti-human MDM2 (SMP14) at 1 : 100 dilution (Santa Cruz Biotechnology), mouse anti-human Rb monoclonal antibody (G3-245) at 1 : 250 dilution, mouse antihuman p53 monoclonal antibody (DO-7) at 1 : 250 dilution, and mouse anti-human actin monoclonal antibody (N 350) (Amersham International). The membrane was then washed with TBS-T and incubated with a horseradish peroxidase-conjugated secondary antibody (1 : 2000 dilution) for 1 h at room temperature. Immunocomplexes formed on the membrane were visualized with an enhanced chemiluminescence (ECL) kit (Amersham Pharmacia Biotech) according to the manufacturer's instructions. (c) Northern blot analysis to detect Rb mRNA expression in Adv/p16-transduced A549 cells. Ten-microgram aliquots of RNA, separated on a 10% agarose gel, were transferred onto a nylon membrane (Amersham Pharmacia Biotech) and hybridized with a a-32 P-dCTPlabeled PCR product of Rb cRNA for 16 h. After being washed with SSC, the membrane was exposed to X-ray ®lm at 7808C overnight Oncogene p16 cleaves Rb through caspase-3 activation K Katsuda et al cells were infected with either Adv/p16 or the adenovirus vector dl312 at multiplicity of infections (MOI) of 100: culture medium was used for a mock infection. Infection with Adv/p16 signi®cantly suppressed the growth of A549 cells when compared with the mock-or dl312-treated cells (P50.01) (Figure 1a ). Growth suppression occurred via cell-cycle arrest, as previously reported (Kataoka et al., 2000) . Moreover, after growth was inhibited, the cell viability of Adv/ p16-infected A549 cells was reduced, starting on day 5 after infection. Induction of programmed cell death was the cause.
Western blot analysis showed that the p16 protein was detectable 2 days after Adv/p16 infection, and its level of expression was maintained for at least 7 days. The Rb protein was dephosphorylated on day 1 and began gradually disappearing on day 4 (Figure 1b) . Adv/p16 infection caused a transient increase of MDM2 expression on day 2, followed by rapid downregulation on day 6; however, the presence of the cleavage product of MDM2, represented by a 60 kDa band, gradually increased starting on day 3. Endogenous p53 expression also transiently increased between days 3 and 6. Unexpectedly, E2F-1 expression did not decrease despite downregulation of Rb (data not shown). To further explore how ectopic p16 expression decreased the levels of Rb, we ®rst performed Northern blot analysis to examine the stability of the Rb mRNA. The assay demonstrated that Rb mRNA expression decreased 24 h after Adv/ p16 infection, the same time that the Rb protein was dephosphorylated; the amount of the Rb transcripts was, however, stable for at least 7 days, even when the cells were undergoing apoptosis (Figure 1c) . These results suggested that Rb was downregulated in a posttranscriptional manner, such as protein cleavage and degradation via the ubiquitin-proteasome pathway.
To further study the regulation of p16-mediated Rb expression, we next performed additional Western blot analysis. As shown in Figure 2a , treatment with Adv/ p16 markedly downregulated expression of the 110 kDa Rb protein. Interestingly, this decrease was inversely correlated with increased expression of the 68 kDa proteolytic fragment of the Rb protein, suggesting that the reduction in Rb levels after Adv/ p16 infection was due to proteolytic cleavage. Several studies have shown that Rb is cleaved by caspases during apoptosis in human cancer cells (An and Dou, 1996; Fattman et al., 1997; Janicke et al., 1996) . It has additionally been reported that treatment with DNAdamaging agents results in cleavage of unphosphorylated Rb into at least two peptide fragments with molecular weights of 48 and 68 kDa (Dou et al., 1995; An and Dou, 1996) . Other groups have shown that Rb can also be cleaved at its C-terminus (Chen et al., 1997; Janicke et al., 1996) .
Previous studies have shown that interleukin 1-converting enzyme (ICE)-like proteases are important in p16-mediated apoptosis and that activation of caspase-3 appears at an early step of apoptosis (Kim et al., 2000) . In the present study, Western blotting with an anti-caspase-3 polyclonal antibody indicated that the levels of procaspase-3 remarkably decreased 3 days after Adv/p16 infection ( Figure 2b ) and expression of its active form increased (data not shown). To con®rm the enzymatic activity of caspase-3, we also performed Western blot analysis for PARP (Lazebnik et al., 1994; Tewari et al., 1995; Nicholson et al., 1995) . In accordance with caspase-3 activation, PARP cleavage was detected 3 days after Adv/p16 infection. However, interestingly, Adv/p16-infected A549 cells underwent apoptosis not immediately after activation of caspase-3 but 5 days after infection (Figure 1a ) when the amount of Rb was signi®cantly reduced because of its cleavage. These data suggested that p16-mediated apoptosis was not preceded by caspase-3 activation but rather, mostly, by Rb inactivation. It has been reported that caspase-7, which is a downstream mediator of caspase-3, is actually responsible for cleaving Rb (Janicke et al., 1998) . This may be the Adv/p16 at 100 MOI and then analysed by immunoblotting using speci®c antibodies against caspase-3, PARP, and cleaved PARP. Equal loading was con®rmed by probing with actin. The cell lysate was frozen and thawed three times and then incubated on ice for 40 min. After centrifugation (15 000 r.p.m. 5 min), the supernatant was stored at 7808C for subsequent analyses. To detect caspase-3, PARP, and cleaved caspase-3, rabbit anti-human caspase-3 polyclonal antibody (556425) at 1 : 1000 dilution (Pharmingen), rabbit anti-human polyclonal PARP antibody (#9542) at 1 : 1000 dilution, and mouse anti-human cleaved-PARP monoclonal antibody (D214) at 1 : 1000 dilution (Cell Signaling Technology) were used p16 cleaves Rb through caspase-3 activation K Katsuda et al reason for our observed delay of Rb cleavage after caspase-3 activation, although further studies will be required to clarify the precise mechanism.
To determine whether the activation of caspase-3 was involved in Rb cleavage during apoptosis, we analysed the eect of a speci®c peptide inhibitor of caspase-3, Ac-DEVD-CHO (Garcia-Calvo et al., 1998) . Treatment of A549 cells with 20 mM Ac-DEVD-CHO completely inhibited Adv/p16-mediated cell death, which was generally observed 5 days after infection (Figure 3a) . To obtain more details about the cell death, A549 cells were stained with the DNAintercalating dye Hoechst 33258 and then examined by¯uorescence microscopy. This analysis showed that Adv/p16-transduced cells underwent apoptosis characterized by extreme condensation and partial fragmentation of nuclei; these morphological changes characteristic of apoptosis were, however, completely blocked when the cells were pretreated with Ac-DEVD-CHO (Figure 3b) .
Indeed, Western blot analysis demonstrated that Ac-DEVD-CHO inhibited the enzymatic activation of caspase-3 3 days after viral infection (Figure 4a ). Finally, we tested whether Ac-DEVD-CHO could block Rb cleavage in Adv/p16-infected A549 cells. As expected, downregulation of Rb was not observed in the presence of Ac-DEVD-CHO (Figure 4b ), suggesting that caspase-3 activation was required to achieve Rb is known to play an important role in regulating apoptosis. Deletion of functional Rb via gene inactivation has been shown to promote cellular apoptosis in a variety of systems Jacks et al., 1992; Clarke et al., 1992; Morgenbesser et al., 1994; Slack et al., 1995; Almasan et al., 1995; Haas-Kogan et al., 1995) . In a previous report, we showed that introduction of the Rb gene into Adv/p16-infected A549 cells blocked apoptosis by 38 ± 43% (Kataoka et al., 2000) . Thus, cleavage of Rb is not only the result of p16-mediated apoptosis but also an essential trigger of apoptosis. The mechanism for how Rb protects cells from apoptosis, however, is not yet clear. Because Rb is important for controlling the transcriptional potential of cells, destruction of Rb may cause the cells' ultimate genetic demise. E2F-1, one of the transcription factors controlled by Rb, is known to promote cell cycle progression beyond the G 1 /S boundary (Shan et al., 1992; Slansky et al., 1993) and to promote apoptosis (Shan and Lee, 1994; Wu and Levine, 1994) . Therefore, we expected that a decrease in Rb would facilitate the release of E2F-1 from the Rb complex so that it could act as an apoptotic inducer. However, Adv/p16 infection did not aect the levels of E2F-1 (data not shown), while the levels of Rb decreased, suggesting that further investigation is necessary to elucidate the relationship between downregulation of Rb and induction of apoptosis.
MDM2, which is known as a negative regulator of p53 function (Momand et al., 1992) , is one of the substrates cleaved by caspases during apoptosis (Nicholson and Thornberry, 1997; Erhardt et al., 1997) . Loss of MDM2 can trigger the p53-dependent apoptotic pathway in vivo (de Rozieres et al., 2000) . Thus, inactivation of MDM2 may enhance p53 functions such as G 1 arrest and apoptosis. MDM2 forms a trimeric complex by binding p53 and Rb proteins Yap et al., 1999) . It has been suggested that when Rb is cleaved, MDM2 is released to become a substrate of caspases during the tumor necrosis factor a-mediated apoptotic process (Tan and Wang, 1998) . Rb may also control the function of p53 through binding MDM2. We found that Adv/p16 infection induced cleavage of MDM2 and upregulation of p53 prior to triggering apoptosis. Others have shown that accumulation of the p53 protein by Adv/p16 sensitizes NSCLC to irradiation (Kawabe et al., 2000) . These observations support the possibility that caspase-3 activation-induced cleavage of MDM2 results in transient p53 activation, leading to induction of apoptosis in Adv/p16-infected A549 cells; direct interactions among these molecules, however, should be further examined.
In summary, we showed that ectopic gene transfer of p16 into A549 human NSCLC cells activated caspase-3, which in turn cleaved Rb and MDM2, leading to initiation of the apoptotic pathway. To the best of our knowledge, this is the ®rst demonstration of the importance of caspase-3-induced Rb cleavage in p16-mediated apoptosis. As p16 is inactivated in many human malignancies, the introduction of exogenous p16 may be a useful tool for treating human cancers.
